| TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity C Govers, Z Sebestyén, J Roszik, M Van Brakel, C Berrevoets, Á Szöőr, ... The Journal of Immunology 193 (10), 5315-5326, 2014 | 56 | 2014 |
| miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers K Panoutsopoulou, M Avgeris, A Scorilas Expert review of molecular diagnostics 18 (11), 963-979, 2018 | 50 | 2018 |
| The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells A Bosch, K Panoutsopoulou, JM Corominas, R Gimeno, G Moreno-Bueno, ... Oncotarget 5 (8), 2065, 2014 | 39 | 2014 |
| tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression K Panoutsopoulou, T Dreyer, J Dorn, E Obermayr, S Mahner, T Gorp, ... Cancers 14 (1), 24, 2021 | 32 | 2021 |
| Circulating exosomal miRNAs: clinical significance in human cancers M Avgeris, K Panoutsopoulou, MA Papadimitriou, A Scorilas Expert Review of Molecular Diagnostics 19 (11), 979-995, 2019 | 31 | 2019 |
| Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer M Avgeris, A Tsilimantou, PK Levis, T Rampias, MA Papadimitriou, ... Carcinogenesis 40 (8), 965-974, 2019 | 22 | 2019 |
| Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming IS Pateras, C Williams, DD Gianniou, AT Margetis, M Avgeris, P Rousakis, ... Journal of Translational Medicine 21 (1), 169, 2023 | 15 | 2023 |
| miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study K Panoutsopoulou, M Avgeris, K Mavridis, T Dreyer, J Dorn, E Obermayr, ... Carcinogenesis 41 (4), 442-451, 2020 | 12 | 2020 |
| miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients K Panoutsopoulou, M Avgeris, P Magkou, K Mavridis, T Dreyer, J Dorn, ... International Journal of Cancer 147 (12), 3560-3573, 2020 | 11 | 2020 |
| Combined treatment with exenatide and cyclosporine A or parstatin 1-26 results in enhanced reduction of infarct size in a rabbit model P Alexopoulos, K Panoutsopoulou, G Vogiatzis, E Koletsis, D Dougenis, ... Journal of Cardiovascular Pharmacology 70 (1), 34-41, 2017 | 11 | 2017 |
| Epi‐miRNAs: Modern mediators of methylation status in human cancers MA Papadimitriou, K Panoutsopoulou, KM Pilala, A Scorilas, M Avgeris Wiley Interdisciplinary Reviews: RNA 14 (2), e1735, 2023 | 10 | 2023 |
| Cancer quiescence: non-coding RNAs in the spotlight K Soureas, MA Papadimitriou, K Panoutsopoulou, KM Pilala, A Scorilas, ... Trends in Molecular Medicine 29 (10), 843-858, 2023 | 6 | 2023 |
| tRNA-derived small RNA 3′ U-tRFValCAC promotes tumour migration and early progression in ovarian cancer K Panoutsopoulou, P Magkou, T Dreyer, J Dorn, E Obermayr, S Mahner, ... European Journal of Cancer 180, 134-145, 2023 | 6 | 2023 |
| Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome KM Pilala, MA Papadimitriou, K Panoutsopoulou, P Barbarigos, P Levis, ... Molecular Therapy-Nucleic Acids 30, 311-322, 2022 | 6 | 2022 |
| Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer Y Liu, W Gong, K Panoutsopoulou, T Singer-Cornelius, K Augustin, ... American Journal of Cancer Research 13 (6), 2471, 2023 | 3 | 2023 |
| Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer K Panoutsopoulou, Y Liu, M Avgeris, T Dreyer, J Dorn, V Magdolen, ... Clinical Biochemistry 114, 43-51, 2023 | 2 | 2023 |
| CDKN2A copy number alteration in bladder cancer: integrative analysis in patient-derived xenografts and cancer patients MA Papadimitriou, KM Pilala, K Panoutsopoulou, P Levis, ... Molecular Therapy Oncology, 2024 | | 2024 |
| The interplay between miR-1245a and BRCA2 in colorectal cancer A Scorilas, K Panoutsopoulou, P Tsiakanikas Annals of Translational Medicine 8 (17), 2020 | | 2020 |
| EP1277 Clinical evaluation of miR-34a in ovarian carcinoma A Arapaki, A Karabelas, K Panoutsopoulou, G Papachristopoulou, ... International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
